Diagnostics comprise less than 5% of hospital costs but their findings influence 60%-70% of healthcare decision-making. India has among the lowest spends on diagnostics in the world due to lack of affordability, accessibility and awareness. How can innovations in diagnostics transform healthcare? Gautam Wankhede, Director of Medical Affairs at leading biotech firm Mylab, speaks to All Indians Matter.